Literature DB >> 12117194

Imaging of cancer of the cervix.

Juergen Scheidler1, Andreas F Heuck.   

Abstract

Cancer of the endometrium is the most common invasive gynecologic malignancy in North America. Although transvaginal sonography is often the initial imaging examination in women with dysfunctional uterine bleeding, MRI offers multifactorial assessment once the diagnosis of endometrial cancer has been established. Specifically, preoperative contrast-enhanced MRI alters the likelihood ratios for myometrial invasion, which in turn affects type and extent of surgery performed. This information also helps identify patients who would most benefit from referral to a tertiary care center for treatment by a gynecologic oncologist.

Entities:  

Mesh:

Year:  2002        PMID: 12117194     DOI: 10.1016/s0033-8389(01)00007-0

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  10 in total

Review 1.  Imaging of female pelvic malignancies regarding MRI, CT, and PET/CT : part 1.

Authors:  Kerstin A Brocker; Celine D Alt; Michael Eichbaum; Christof Sohn; Hans-Ulrich Kauczor; Peter Hallscheidt
Journal:  Strahlenther Onkol       Date:  2011-09-23       Impact factor: 3.621

2.  Efficacy of transvaginal contrast-enhanced MRI in the early staging of cervical carcinoma.

Authors:  Deniz Akata; Ulku Kerimoglu; Tuncay Hazirolan; Musturay Karcaaltincaba; Faruk Köse; Mustafa N Ozmen; Okan Akhan
Journal:  Eur Radiol       Date:  2005-01-27       Impact factor: 5.315

3.  Role of computed tomography (CT) scan in staging of cervical carcinoma.

Authors:  T V Prasad; S Thulkar; S Hari; D N Sharma; S Kumar
Journal:  Indian J Med Res       Date:  2014-05       Impact factor: 2.375

Review 4.  Imaging of female pelvic malignancies regarding MRI, CT, and PET/CT: Part 2.

Authors:  Celine D Alt; Kerstin A Brocker; Michael Eichbaum; Christof Sohn; Florian U Arnegger; Hans-Ulrich Kauczor; Peter Hallscheidt
Journal:  Strahlenther Onkol       Date:  2011-10-28       Impact factor: 3.621

5.  Clinical significance of tumor volume and lymph node involvement assessed by MRI in stage IIB cervical cancer patients treated with concurrent chemoradiation therapy.

Authors:  Dae Woo Lee; Young Tae Kim; Jae Hoon Kim; Sunghoon Kim; Sang Wun Kim; Eun Ji Nam; Jae Wook Kim
Journal:  J Gynecol Oncol       Date:  2010-03-31       Impact factor: 4.401

6.  Localized cervical cancer (stage <IIB): accuracy of MR imaging in planning less extensive surgery.

Authors:  R Manfredi; B Gui; A Giovanzana; S Marini; M Di Stefano; G Zannoni; G Scambia; L Bonomo
Journal:  Radiol Med       Date:  2009-05-14       Impact factor: 3.469

7.  Contribution of diffusion-weighted imaging to diagnosis and staging of cervical cancer.

Authors:  Tuna Demirbaş; Tan Cimilli; Sibel Bayramoğlu; Nurten Turan Güner; Elif Hocaoğlu; Ercan Inci
Journal:  Balkan Med J       Date:  2014-06-01       Impact factor: 2.021

Review 8.  [Uterine Cervical Cancer: Emphasis on Revised FIGO Staging 2018 and MRI].

Authors:  Weon Jang; Ji Soo Song
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2021-09-27

Review 9.  Magnetic resonance imaging of the cervix.

Authors:  Khashayar Rafat Zand; Caroline Reinhold; Hisashi Abe; Sharad Maheshwari; Ahmed Mohamed; Daniel Upegui
Journal:  Cancer Imaging       Date:  2007-05-28       Impact factor: 3.909

10.  Improving Global Outcomes in Cervical Cancer: The Time Has Come for International Federation of Gynecology and Obstetrics Staging to Formally Incorporate Advanced Imaging.

Authors:  Shruti Jolly; Shitanshu Uppal; Neerja Bhatla; Carolyn Johnston; Katherine Maturen
Journal:  J Glob Oncol       Date:  2017-03-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.